Chemoinformaics analysis of 11-Dodecenoic acid
| Molecular Weight | 198.306 | nRot | 10 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 2 |
| Exact Molecular Weight | 198.162 | nRing | 0 |
| Solubility: LogS | -3.401 | nHRing | 0 |
| Solubility: LogP | 4.351 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 36.3134 |
| nHD | 1 | BPOL | 22.9386 |
| QED | 0.428 |
| Synth | 1.906 |
| Natural Product Likeliness | 0.953 |
| NR-PPAR-gamma | 0.966 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -5.076 |
| MDCK | 0.0000307 |
| BBB | 0.343 |
| PPB | 0.961415 |
| VDSS | 0.277 |
| FU | 0.0217844 |
| CYP1A2-inh | 0.084 |
| CYP1A2-sub | 0.272 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.335 |
| CYP2c9-inh | 0.125 |
| CYP2c9-sub | 0.979 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.29 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.038 |
| CL | 2.251 |
| T12 | 0.787 |
| hERG | 0.016 |
| Ames | 0.01 |
| ROA | 0.107 |
| SkinSen | 0.924 |
| Carcinogencity | 0.133 |
| EI | 0.988 |
| Respiratory | 0.797 |
| NR-Aromatase | 0.021 |
| Antiviral | Yes |
| Prediction | 0.604668 |